The effects of breast feeding on the outcome of rotavirus (RV) infection were studied prospectively in groups of infants fed exclusively with mother's (breast) milk, commercial (bottle) formula, or combination of both, before, during and after naturally acquired infection with RV. The antibody activity to RV in the serum and milk was determined by an ELISA assay, and sequentially collected fecal specimens were tested for the presence and quantitation of RV and bifidobacteria species by ELISA, electron microscopy, gram staining and gas-l iquid chromatography. The observed frequency of RV induced diarrhea was significantly lower in breast fed compared to bottle fed infants. However, the recovery rates and quantitation of RV in feces of breast or bottle fed infants were remarkably similar. All breast fed infants exhibited pronounced degree of intestinal colonization with bifidobacteria. Such colonization was not observed in bottle fed infants. Significantly, the severity of diarrhea in patients with RV infection correlated better with lack of colonization with bifidobacteria than with magnitude of RV replication. These observations suggest that although, breast feeding is beneficial against development of diarrhea during RV infection, this effect is mediated more by alterations in the bacterial flora of the intestine than by l imitation of virus rep1 ication.
of Pediatrics, Buffalo, New York.
The effects of breast feeding on the outcome of rotavirus (RV) infection were studied prospectively in groups of infants fed exclusively with mother's (breast) milk, commercial (bottle) formula, or combination of both, before, during and after naturally acquired infection with RV. The antibody activity to RV in the serum and milk was determined by an ELISA assay, and sequentially collected fecal specimens were tested for the presence and quantitation of RV and bifidobacteria species by ELISA, electron microscopy, gram staining and gas-l iquid chromatography. The observed frequency of RV induced diarrhea was significantly lower in breast fed compared to bottle fed infants. However, the recovery rates and quantitation of RV in feces of breast or bottle fed infants were remarkably similar. All breast fed infants exhibited pronounced degree of intestinal colonization with bifidobacteria. Such colonization was not observed in bottle fed infants. Significantly, the severity of diarrhea in patients with RV infection correlated better with lack of colonization with bifidobacteria than with magnitude of RV replication. These observations suggest that although, breast feeding is beneficial against development of diarrhea during RV infection, this effect is mediated more by alterations in the bacterial flora of the intestine than by l imitation of virus rep1 ication.
EFFECT OF METOCLOPRAMIDE (MC) ON FALTERING MILK PRODUCTION BY MOTHERS OF PREMATURE INFANTS. Richard
644 A-Ehrenkranz and Barbara A-Ackerman (Spon. by I . ~ross). Yale Univ. Sch. of Med., Dept. of Ped., New Haven, CT.
-MC treatment has been shown to augment milk production and stimulate prolactin (PRL) secretion in women who develop defective lactation after a full-term normal del ivery. We have studied the effect of oral MC treatment in 7 women who had delivered premature infants (BW 1127+191 gm, GA 29.0+1,5 wk, mean + SE) and who were having difficulty maintaining lactation by -regular milk expression with an electric and/or hand pump. Each woman had noted a gradual decrease in the total daily volume of expressed milk during the first several weeks of lactation. MC therapy (10 mg every 8 hrs for 7 days) was begun after increases in the number of expressions/day and dietary suggest ions failed to Increase milk production; it was initiated at 42+6 days postpartum (range 17-67 days). Daily milk volume increased in each patient between the first and seventh day of therapy; from 7 5 5 8 ml/day to 182+24 ml/day respectively (p<0.001).
Serum PRL levels were measureday RIA in 4 of these women on 2 occasions. Basal PRL levels were 29+10 ng/ml (range 29 to 56 ng/ml) and were obtained prior to onret of MC therapy and prior to milk expression (laboratory normal for non-lactating women < 20 ng/ml). After 5 to 7 days of MC, serum PRL levels were 123275 ng/ml (range 70 to 225) 30 min after milk expression. These data demnstrate that the faltering milk production noted in some mothers of premature infants can be successfully treated with MC, and suggest that stimulation of PRL secretion by MC accounts for the significantly increased daily milk volume. 
NUTRIENT BALANCE STUDIES IN VERY-LOW-BI RTH WEIGHT (VLBW) INFANTS WITH ILEOSTOMI ES. Richard
Babies and Childrens Hospital, Dept. of pediatrics, kleveland. Green light is useful in the treatment of neonatal jaundice, and has been reported to be as effective as narrow-spectrum, high-intensity blue light and more effective than standard white light. These reports have been met with skepticism because fluorescent green lights have a spectral output with limited overlap with the absorption band of bilirubin and are less effective than either white or blue lights in producing the configurational isomer of bilirubin (E-bilirubin). Recent studies indicate that the formation and excretion of lumirubin, a structural isomer of bilirubin, is more important than E-bilirubin for pigment elimination in jaundiced infants receiving phototherapy. To assess the effectiveness of green light in producing the structural isomer, I have measured the action spectrum for the formation of lumirubin. I have found that the quantum yield for lumirubin formation (lumirubin production per photon absorbed by bilirubin) is wavelength dependent. The quantum yield was constant for blue light between 430 and 470 nm. Green light at 500 nm had a quantum yield more than twice that of blue light, while 510 urn light had a quantum yield nearly four-fold higher. This unexpected wavelength dependence for lumirubin formation suggests that green light is preferentially absorbed by that half of the bilirubin molecule which undergoes the photochemical reaction to lumirubin. The higher quantum yield for lumirubin formation provides an explanation for the observed clinical efficacy of green fluorescent lights. These results suggest that phototherapy lights with high intensity in the spectral region above 490 and no irradiation in the genotoxic region below 450 nm may prove both safer and more effective than any lamp now in use. studies have shown that bilirubin is converted to more polar isomeric forms when exposed to light. There are two types of isomers formed, configurational (E-bilirubins) and structural (lumirubins). The relative contribution of these two photoproducts to the response of neonates to phototherapy has not previously been established. The E-bilirubins are formed more rapidly than the lumirubins; however, the decline in plasma bilirubin depends not only upon formation but also upon excretion. In a previous study we found that the excretion of the E-bilirubins in premature infants is too slow (serum halflife = 15 hours) to account for observed reduction in bilirubin levels. We report here evidence that excretion of lumirubins is the principal route of pigment elimination during phototherapy. The study population consisted of nine premature infants with a mean gestational age of 31 1: 2 weeks (i S.D.). Bile samples were obtained during phototherapy and analyzed by high pressure liquid chromatography for bilirubin and its isomers. We found that the major pigment, and in some infants the only pigment, present in the bile was lumirubins. Five serum samples were obtained from each infant during the first 90 minutes after stopping phototherapy, and the measured serum half-life of lumirubins was 120 i 25 minutes. This is the first demonstration that lumirubins are more important than E-bilirubins to the efficacy of phototherapy. Bolus feedings cause wide v a r i a t i o n s i n p e r i p h e r a l blood flow. I n s u f f i c i e n t flow t o non-vital p e r i p h e r a l organs may be undesirable i n c r i t i c a l l y ill, VLBW neonates.
WHERE DOES THE BILIRUBIN GO WHEN YOU TURN ON THE

EFFECTS OF CONSTANT NASOGASTRIC INFUSION
Tb determine &ether constant nascgastric infusion is a suitable a1 ternat ive, we monitored cardiovascular function i n 26 neonates selected fran 112 NICU admissions < 15009 a t b i r t h . These p a t i e n t s were p r o s p e c t i v e l y matched f o r severity of i l l n e s s and randomly assigned t o be held NPO f o r 7 days (n=12) o r fed within 24 hours of b i r t h (~1 4 , see related abstract). Vital signs were monitored f o r 1 hour on days 1, 3 , and 7 of l i f e , a s were peripheral blood flow and resistance, measured by impedence plethymqraphy. P e r i p e h r a l blood flow, p e r i p h e r a l v a s c u l a r r e s i s t a n c e , heart r a t e , and mean a r t e r i a l pressure, were not significantl y d i f f e r e n t between t h e two groups. The incidence of necrotizing e n t e r o c o l i t i s was 25% (3/12) and 29% (4114) i n NPO and fed groups, respectively. W e conclude t h a t periphera l blood flow i n c r i t i c a l l y ill VLBW neonates, receiving e a r l y constant nasogastric infuison, is not significantly d i f f e r e n t from t h o s e i n f a n t s h e l d NPO. Thus, c o n s t a n t nascgastric infusion may avoid the adverse e f f e c t s of b l u s feedings on p e r i p h e r a l blood flow i n s i c k neonates and therefore, may help lower the r i s k of NEC due to variable o r inadequate blood flow t o non-vital organs.
